Vnitr Lek 2011, 57(5):511-515

Morbus Ormond (idiopatic retroperitoneal fibrosis)

A. Michaligová1,*, L. Plank2, A. Ježíková1, V. Maňka1, P. Makovický1, M. Mokáň1
1 I. Interná klinika Jesseniovej lekárskej fakulty UK a Univerzitnej nemocnice Martin, Slovenská republika, prednosta prof. MUDr. Marián Mokáň, DrSc., FRCP Edin
2 Ústav patologickej anatómie Jesseniovej lekárskej fakulty UK a Univerzitnej nemocnice Martin, Slovenská republika, prednosta prof. MUDr. Lukáš Plank, CSc.

Idiopathic retroperitoneal fibrosis (IRF) is a rare condition characterized by the development of fibrotic tissue around the abdominal aorta and iliac arteries and often involves structures as ureters and the inferior vena cava. The age at onset of signs and symptoms is between 40-60 years, males predominane over females. In most cases the clinical manifestation is presented as compressive syndrom of ureters, therefore the first known cases were described by urologists. In this report we present the case of 37-years old male examinated for persistent fever about 38 °C and high inflammatory activity in spite of empiric antibiotic therapy. Positron emission tomography (PET) showed locality of high metabolic activity of fluorodeoxyglucose with maximum paraaortal left. Microscopic examination of extracted mass showed presence of fibrous and inflammatory components. With clinical presentation, imaging and histological findings we made out the diagnosis of idiopathic retroperitoneal fibrosis - morbus Ormond.

Keywords: idiopatic retroperitoneal fibrosis; Ormond's disease; fever

Received: June 9, 2010; Accepted: December 6, 2010; Published: May 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Michaligová A, Plank L, Ježíková A, Maňka V, Makovický P, Mokáň M. Morbus Ormond (idiopatic retroperitoneal fibrosis). Vnitr Lek. 2011;57(5):511-515.
Download citation

References

  1. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367: 241-251. Go to original source... Go to PubMed...
  2. Albarran J. Rétention rénale par périurétérite. Libération externe de l'uretère. Assoc Fr Urol 1905; 9: 511-517.
  3. Ormond JK. Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J Urol 1948; 59: 1072-1079. Go to original source... Go to PubMed...
  4. Uibu T, Oksa P, Auvinen A et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 2004; 363: 1422-1426. Go to original source... Go to PubMed...
  5. Gilkeson GS, Allen NB. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 1996; 22: 356-364. Go to original source...
  6. Armigliato M, Paolini R, Bianchini E et al. Hashimoto's thyroiditis and Graves' disease associated with retroperitoneal fibrosis. Thyroid 2002; 12: 829-831. Go to original source... Go to PubMed...
  7. Littlejohn GO, Keystone EC. The association of retroperitoneal fibrosis with systemic vasculitis and HLA-B27: a case report and review of the literature. J Rheumatol 1981; 8: 665-669. Go to PubMed...
  8. Vaglio A, Greco P, Corradi D et al. Autoimmune aspect of chronic periaortitis. Autoimmun Rev 2006; 5: 458-464. Go to original source... Go to PubMed...
  9. Vaglio A, Corradi D, Manenti L et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003; 114: 454-462. Go to original source... Go to PubMed...
  10. Martorana D, Vaglio A, Greco D et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 2006; 55: 126-130. Go to original source... Go to PubMed...
  11. Allibone GW, Saxton HM. The association of aorto-iliac aneurysms with ureteral obstruction. Urol Radiol 1980; 1: 205-210. Go to original source... Go to PubMed...
  12. Lorentzen JE, Sørensen IN, Brun B et al. Abdominal aortic aneurysm in combination with retroperitoneal fibrosis. Acta Chir Scand Suppl 1980; 502: 94-97. Go to PubMed...
  13. Stewart TW jr. Idiopathic retroperitoneal fibrosis - past and present. NY State J Med 1989; 89: 503-504.
  14. Wu J, Catalano E, Coppola D. Retroperitoneal fibrosis (Ormond's disease): clinical pathologic study of eight cases. Cancer Control 2002; 9: 432-437. Go to original source... Go to PubMed...
  15. Serratrice J, Granel B, De Roux B et al. "Coated aorta": a new sign of Erdheim-Chester disease. J Rheumatol 2000; 6: 1550-1553.
  16. van Bommel EF, Siemes C, Hak LE et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednison. Am J Kidney Dis 2007; 49: 615-625. Go to original source... Go to PubMed...
  17. Lepor H, Walsh PC. Idiopathic retroperitoneal fibrosis. J Urol 1979; 122: 1-6. Go to original source... Go to PubMed...
  18. Miller OF, Smith LJ, Ferrara EX et al. Presentation of idiopathic retroperitoneal fibrosis in the pediatric population. J Pediatr Surg 2003; 38: 1685-1688. Go to original source... Go to PubMed...
  19. Průcha M, Beňo P, Bartůňek M et al. Idiopatická retroperitoneálna fibróza - Ormondova choroba: kazuistika. Vnitř Lék 2008; 54: 282-286. Go to PubMed...
  20. Jois RN, Kerrigan N, Scott DG. Mycophenolate mofetil for maintenance of remision in idiopathic retroperitoneal fibrosis. Rheumatology (Oxford) 2007; 46: 717-718. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.